CIRCX
Price
$71.27
Change
-$1.60 (-2.20%)
Updated
Dec 18 closing price
RAPZX
Price
$9.86
Change
-$0.20 (-1.99%)
Updated
Dec 18 closing price
Ad is loading...

CIRCX vs RAPZX

Header iconCIRCX vs RAPZX Comparison
Open Charts CIRCX vs RAPZXBanner chart's image
American Funds Capital Income Bldr 529C
Price$71.27
Change-$1.60 (-2.20%)
VolumeN/A
CapitalizationN/A
Cohen & Steers Real Assets Z
Price$9.86
Change-$0.20 (-1.99%)
VolumeN/A
CapitalizationN/A
CIRCX vs RAPZX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CIRCX vs. RAPZX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CIRCX is a Buy and RAPZX is a Buy.

FUNDAMENTALS
Fundamentals
CIRCX has more cash in the bank: 108B vs. RAPZX (958M). RAPZX pays higher dividends than CIRCX: RAPZX (2.66) vs CIRCX (2.49). CIRCX was incepted earlier than RAPZX: CIRCX (23 years) vs RAPZX (13 years). CIRCX (106.00) and RAPZX (104.00) have comparable annual turnover. RAPZX has a lower initial minimum investment than CIRCX: RAPZX (0) vs CIRCX (250). CIRCX annual gain was more profitable for investors over the last year : 12.56 vs. RAPZX (6.37). RAPZX return over 5 years is better than : 30.23 vs. CIRCX (28.67).
CIRCXRAPZXCIRCX / RAPZX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence23 years13 years-
Gain YTD11.1515.180215%
Front LoadN/AN/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets108B958M11,273%
Annual Yield % from dividends2.492.6694%
Returns for 1 year12.566.37197%
Returns for 3 years13.499.87137%
Returns for 5 years28.6730.2395%
Returns for 10 years55.9842.04133%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VRSN195.210.01
+0.01%
VeriSign
WRLD116.19-1.62
-1.38%
World Acceptance Corp
TLYS3.38-0.07
-2.03%
Tilly's
SYBX1.45-0.03
-2.36%
Synlogic
VRNA41.66-1.02
-2.39%
Verona Pharma plc